Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Generic Drugs Market Size Analysis from 2022 to 2027
1.5.1 Global Generic Drugs Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Generic Drugs Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Generic Drugs Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Generic Drugs Industry Impact
Chapter 2 Global Generic Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global Generic Drugs (Volume and Value) by Type
2.1.1 Global Generic Drugs Consumption and Market Share by Type (2016-2021)
2.1.2 Global Generic Drugs Revenue and Market Share by Type (2016-2021)
2.2 Global Generic Drugs (Volume and Value) by Application
2.2.1 Global Generic Drugs Consumption and Market Share by Application (2016-2021)
2.2.2 Global Generic Drugs Revenue and Market Share by Application (2016-2021)
2.3 Global Generic Drugs (Volume and Value) by Regions
2.3.1 Global Generic Drugs Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Generic Drugs Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Generic Drugs Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Generic Drugs Consumption by Regions (2016-2021)
4.2 North America Generic Drugs Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Generic Drugs Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Generic Drugs Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Generic Drugs Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Generic Drugs Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Generic Drugs Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Generic Drugs Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Generic Drugs Sales, Consumption, Export, Import (2016-2021)
4.10 South America Generic Drugs Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Generic Drugs Market Analysis
5.1 North America Generic Drugs Consumption and Value Analysis
5.1.1 North America Generic Drugs Market Under COVID-19
5.2 North America Generic Drugs Consumption Volume by Types
5.3 North America Generic Drugs Consumption Structure by Application
5.4 North America Generic Drugs Consumption by Top Countries
5.4.1 United States Generic Drugs Consumption Volume from 2016 to 2021
5.4.2 Canada Generic Drugs Consumption Volume from 2016 to 2021
5.4.3 Mexico Generic Drugs Consumption Volume from 2016 to 2021
Chapter 6 East Asia Generic Drugs Market Analysis
6.1 East Asia Generic Drugs Consumption and Value Analysis
6.1.1 East Asia Generic Drugs Market Under COVID-19
6.2 East Asia Generic Drugs Consumption Volume by Types
6.3 East Asia Generic Drugs Consumption Structure by Application
6.4 East Asia Generic Drugs Consumption by Top Countries
6.4.1 China Generic Drugs Consumption Volume from 2016 to 2021
6.4.2 Japan Generic Drugs Consumption Volume from 2016 to 2021
6.4.3 South Korea Generic Drugs Consumption Volume from 2016 to 2021
Chapter 7 Europe Generic Drugs Market Analysis
7.1 Europe Generic Drugs Consumption and Value Analysis
7.1.1 Europe Generic Drugs Market Under COVID-19
7.2 Europe Generic Drugs Consumption Volume by Types
7.3 Europe Generic Drugs Consumption Structure by Application
7.4 Europe Generic Drugs Consumption by Top Countries
7.4.1 Germany Generic Drugs Consumption Volume from 2016 to 2021
7.4.2 UK Generic Drugs Consumption Volume from 2016 to 2021
7.4.3 France Generic Drugs Consumption Volume from 2016 to 2021
7.4.4 Italy Generic Drugs Consumption Volume from 2016 to 2021
7.4.5 Russia Generic Drugs Consumption Volume from 2016 to 2021
7.4.6 Spain Generic Drugs Consumption Volume from 2016 to 2021
7.4.7 Netherlands Generic Drugs Consumption Volume from 2016 to 2021
7.4.8 Switzerland Generic Drugs Consumption Volume from 2016 to 2021
7.4.9 Poland Generic Drugs Consumption Volume from 2016 to 2021
Chapter 8 South Asia Generic Drugs Market Analysis
8.1 South Asia Generic Drugs Consumption and Value Analysis
8.1.1 South Asia Generic Drugs Market Under COVID-19
8.2 South Asia Generic Drugs Consumption Volume by Types
8.3 South Asia Generic Drugs Consumption Structure by Application
8.4 South Asia Generic Drugs Consumption by Top Countries
8.4.1 India Generic Drugs Consumption Volume from 2016 to 2021
8.4.2 Pakistan Generic Drugs Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Generic Drugs Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Generic Drugs Market Analysis
9.1 Southeast Asia Generic Drugs Consumption and Value Analysis
9.1.1 Southeast Asia Generic Drugs Market Under COVID-19
9.2 Southeast Asia Generic Drugs Consumption Volume by Types
9.3 Southeast Asia Generic Drugs Consumption Structure by Application
9.4 Southeast Asia Generic Drugs Consumption by Top Countries
9.4.1 Indonesia Generic Drugs Consumption Volume from 2016 to 2021
9.4.2 Thailand Generic Drugs Consumption Volume from 2016 to 2021
9.4.3 Singapore Generic Drugs Consumption Volume from 2016 to 2021
9.4.4 Malaysia Generic Drugs Consumption Volume from 2016 to 2021
9.4.5 Philippines Generic Drugs Consumption Volume from 2016 to 2021
9.4.6 Vietnam Generic Drugs Consumption Volume from 2016 to 2021
9.4.7 Myanmar Generic Drugs Consumption Volume from 2016 to 2021
Chapter 10 Middle East Generic Drugs Market Analysis
10.1 Middle East Generic Drugs Consumption and Value Analysis
10.1.1 Middle East Generic Drugs Market Under COVID-19
10.2 Middle East Generic Drugs Consumption Volume by Types
10.3 Middle East Generic Drugs Consumption Structure by Application
10.4 Middle East Generic Drugs Consumption by Top Countries
10.4.1 Turkey Generic Drugs Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Generic Drugs Consumption Volume from 2016 to 2021
10.4.3 Iran Generic Drugs Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Generic Drugs Consumption Volume from 2016 to 2021
10.4.5 Israel Generic Drugs Consumption Volume from 2016 to 2021
10.4.6 Iraq Generic Drugs Consumption Volume from 2016 to 2021
10.4.7 Qatar Generic Drugs Consumption Volume from 2016 to 2021
10.4.8 Kuwait Generic Drugs Consumption Volume from 2016 to 2021
10.4.9 Oman Generic Drugs Consumption Volume from 2016 to 2021
Chapter 11 Africa Generic Drugs Market Analysis
11.1 Africa Generic Drugs Consumption and Value Analysis
11.1.1 Africa Generic Drugs Market Under COVID-19
11.2 Africa Generic Drugs Consumption Volume by Types
11.3 Africa Generic Drugs Consumption Structure by Application
11.4 Africa Generic Drugs Consumption by Top Countries
11.4.1 Nigeria Generic Drugs Consumption Volume from 2016 to 2021
11.4.2 South Africa Generic Drugs Consumption Volume from 2016 to 2021
11.4.3 Egypt Generic Drugs Consumption Volume from 2016 to 2021
11.4.4 Algeria Generic Drugs Consumption Volume from 2016 to 2021
11.4.5 Morocco Generic Drugs Consumption Volume from 2016 to 2021
Chapter 12 Oceania Generic Drugs Market Analysis
12.1 Oceania Generic Drugs Consumption and Value Analysis
12.2 Oceania Generic Drugs Consumption Volume by Types
12.3 Oceania Generic Drugs Consumption Structure by Application
12.4 Oceania Generic Drugs Consumption by Top Countries
12.4.1 Australia Generic Drugs Consumption Volume from 2016 to 2021
12.4.2 New Zealand Generic Drugs Consumption Volume from 2016 to 2021
Chapter 13 South America Generic Drugs Market Analysis
13.1 South America Generic Drugs Consumption and Value Analysis
13.1.1 South America Generic Drugs Market Under COVID-19
13.2 South America Generic Drugs Consumption Volume by Types
13.3 South America Generic Drugs Consumption Structure by Application
13.4 South America Generic Drugs Consumption Volume by Major Countries
13.4.1 Brazil Generic Drugs Consumption Volume from 2016 to 2021
13.4.2 Argentina Generic Drugs Consumption Volume from 2016 to 2021
13.4.3 Columbia Generic Drugs Consumption Volume from 2016 to 2021
13.4.4 Chile Generic Drugs Consumption Volume from 2016 to 2021
13.4.5 Venezuela Generic Drugs Consumption Volume from 2016 to 2021
13.4.6 Peru Generic Drugs Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Generic Drugs Consumption Volume from 2016 to 2021
13.4.8 Ecuador Generic Drugs Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Generic Drugs Business
14.1 Teva
14.1.1 Teva Company Profile
14.1.2 Teva Generic Drugs Product Specification
14.1.3 Teva Generic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Sanofi
14.2.1 Sanofi Company Profile
14.2.2 Sanofi Generic Drugs Product Specification
14.2.3 Sanofi Generic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Sun Pharmaceutical
14.3.1 Sun Pharmaceutical Company Profile
14.3.2 Sun Pharmaceutical Generic Drugs Product Specification
14.3.3 Sun Pharmaceutical Generic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Novartis - Sandoz
14.4.1 Novartis - Sandoz Company Profile
14.4.2 Novartis - Sandoz Generic Drugs Product Specification
14.4.3 Novartis - Sandoz Generic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Pfizer (Hospira)
14.5.1 Pfizer (Hospira) Company Profile
14.5.2 Pfizer (Hospira) Generic Drugs Product Specification
14.5.3 Pfizer (Hospira) Generic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Mylan
14.6.1 Mylan Company Profile
14.6.2 Mylan Generic Drugs Product Specification
14.6.3 Mylan Generic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Lupin
14.7.1 Lupin Company Profile
14.7.2 Lupin Generic Drugs Product Specification
14.7.3 Lupin Generic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Fresenius Kabi
14.8.1 Fresenius Kabi Company Profile
14.8.2 Fresenius Kabi Generic Drugs Product Specification
14.8.3 Fresenius Kabi Generic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Aspen
14.9.1 Aspen Company Profile
14.9.2 Aspen Generic Drugs Product Specification
14.9.3 Aspen Generic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Aurobindo
14.10.1 Aurobindo Company Profile
14.10.2 Aurobindo Generic Drugs Product Specification
14.10.3 Aurobindo Generic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Stada Arzneimittel
14.11.1 Stada Arzneimittel Company Profile
14.11.2 Stada Arzneimittel Generic Drugs Product Specification
14.11.3 Stada Arzneimittel Generic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Valeant
14.12.1 Valeant Company Profile
14.12.2 Valeant Generic Drugs Product Specification
14.12.3 Valeant Generic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 Dr. Reddy`s
14.13.1 Dr. Reddy`s Company Profile
14.13.2 Dr. Reddy`s Generic Drugs Product Specification
14.13.3 Dr. Reddy`s Generic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.14 Hikma
14.14.1 Hikma Company Profile
14.14.2 Hikma Generic Drugs Product Specification
14.14.3 Hikma Generic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.15 Krka Group
14.15.1 Krka Group Company Profile
14.15.2 Krka Group Generic Drugs Product Specification
14.15.3 Krka Group Generic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.16 ENDO (Par Pharmaceutical)
14.16.1 ENDO (Par Pharmaceutical) Company Profile
14.16.2 ENDO (Par Pharmaceutical) Generic Drugs Product Specification
14.16.3 ENDO (Par Pharmaceutical) Generic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.17 Apotex
14.17.1 Apotex Company Profile
14.17.2 Apotex Generic Drugs Product Specification
14.17.3 Apotex Generic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.18 Zydus Cadila
14.18.1 Zydus Cadila Company Profile
14.18.2 Zydus Cadila Generic Drugs Product Specification
14.18.3 Zydus Cadila Generic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.19 Nichi-Iko Pharmaceutical
14.19.1 Nichi-Iko Pharmaceutical Company Profile
14.19.2 Nichi-Iko Pharmaceutical Generic Drugs Product Specification
14.19.3 Nichi-Iko Pharmaceutical Generic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.20 Cipla
14.20.1 Cipla Company Profile
14.20.2 Cipla Generic Drugs Product Specification
14.20.3 Cipla Generic Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Generic Drugs Market Forecast (2022-2027)
15.1 Global Generic Drugs Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Generic Drugs Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Generic Drugs Value and Growth Rate Forecast (2022-2027)
15.2 Global Generic Drugs Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Generic Drugs Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Generic Drugs Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Generic Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Generic Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Generic Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Generic Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Generic Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Generic Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Generic Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Generic Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Generic Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Generic Drugs Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Generic Drugs Consumption Forecast by Type (2022-2027)
15.3.2 Global Generic Drugs Revenue Forecast by Type (2022-2027)
15.3.3 Global Generic Drugs Price Forecast by Type (2022-2027)
15.4 Global Generic Drugs Consumption Volume Forecast by Application (2022-2027)
15.5 Generic Drugs Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
